Search Results - "H. Poliwoda"

Transplantation of Allogeneic CD34+ Blood Cells by Link, Hartmut, Arseniev, Lubomir, Bähre, Oliver, Kadar, Janos G., Diedrich, Helmut, Poliwoda, Hubert

“…Pluripotent stem cells of hematopoiesis and lymphopoiesis are among the CD34+ cells in blood or bone marrow. After granulocyte-colony stimulating factor…”
Get full text

Hepatitis B associated liver failure following bone marrow transplantation by Caselitz, M., Link, H., Hein, R., Maschek, H., Böker, K., Poliwoda, H., Manns, M.P.

“…Background: Several cases have been reported showing clearance of HBsAg in chronic hepatitis B carriers due to adoptive transfer of immunity by an hepatitis B…”
Get full text

Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma by BOKEMEYER, C, SCHMOLL, H.-J, VAN RHEE, J, KUCZYK, M, SCHUPPERT, F, POLIWODA, H

“…With the increasing cure rate of patients treated for Hodgkin's and non-Hodgkin's lymphoma, the evaluation of late effects on gonadal function remains an…”
Get full text

Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-α after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen by Atzpodien, J., Lopez Hänninen, E., Kirchner, H., Franzke, A., Körfer, A., Volkenandt, M., Duensing, S., Schomburg, A., Chaitchik, S., Poliwoda, H.

“…Both chemotherapy and interleukin-2 and/or interferon-α produce objective responses in a proportion of advanced malignant melanoma patients. While duration of…”
Get full text

Optimization and Reproducibility of Random Amplified Polymorphic DNA in Human by Benter, T., Papadopoulos, S., Pape, M., Manns, M., Poliwoda, H.

“…In this work, we have optimized random amplified polymorphic DNA (RAPD) for the use of human DNA in altering the concentration of the reaction components and…”
Get full text

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma by Harstrick, A, Schmoll, H J, Wilke, H, Köhne-Wömpner, C H, Stahl, M, Schöber, C, Casper, J, Bruderek, L, Schmoll, E, Bokemeyer, C

“…Thirty patients with metastatic progressive germ cell carcinoma who failed to be cured with first-line cisplatin chemotherapy were treated with a salvage…”
Get more information

Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell lines by Harstrick, A, Schmoll, H J, Sass, G, Poliwoda, H, Rustum, Y

“…The activity of a new organometallic compound, titanocendichloride, was evaluated in doxorubicin- and cisplatin-resistant human ovarian carcinoma cell lines in…”
Get more information

Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid by Atzpodien, J, Kirchner, H, Duensing, S, Lopez Hänninen, E, Franzke, A, Buer, J, Probst, M, Anton, P, Poliwoda, H

“…We conducted a phase I/II clinical trial evaluating the sequential outpatient combination of S.C. recombinant human interleukin-2 (rIL-2; given at 10 MIU/m2…”
Get full text

Final report of a phase II study of interleukin 2 and interferon α in patients with metastatic melanoma by KRUIT, W. H. J, GOEY, S. H, CALABRESI, F, LINDEMANN, A, STAHEL, R. A, POLIWODA, H, OSTERWALDER, B, STOTER, G

“…Fifty-seven patients with metastatic melanoma were treated with interleukin 2 (IL-2) 7.8 MIU m-2 day-1 as a continuous infusion for 4 days combined with…”
Get full text

Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on circulating platelets by AVENARIUS, H. J, FREUND, M, DEINHARDT, J, POLIWODA, H

“…The effect on platelets of rhG-CSF was studied in 20 healthy volunteers with the thrombometer, a specially developed device which is described in detail…”
Get full text

Treatment of chronic arterial occlusions with streptokinase by Poliwoda, H

Get full text

Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell lines in vivo and in vitro by Harstrick, A, Casper, J, Guba, R, Wilke, H, Poliwoda, H, Schmoll, H J

“…Cisplatin is a backbone of any combination chemotherapy currently in use for the treatment for nonseminomatous germ cell tumors. Recently new platinum analogs…”
Get more information

Linomide and interleukin-2 in patients with advanced renal cell carcinoma by Deckert, M, Franzke, A, Buer, J, Probst, M, Duensing, S, Lopez-Haenninen, E, Kirchner, H, Poliwoda, H, Atzpodien, J

“…Quinoline-3-carboxamide (Linomide) is a novel, synthetic immunomodulator acting via immunologic and non-immunologic mechanisms. It has shown efficacy against…”
Get more information

A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours by Bokemeyer, C, Schmoll, H J, Harstrick, A, Illiger, H J, Metzner, B, Räth, U, Hohnloser, J, Clemm, C, Berdel, W, Siegert, W

“…In order to improve the survival of patients with metastatic advanced disease germ cell tumours (according to Indiana University classification), 77 patients…”
Get more information

Treatment of metastatic colorectal cancer patients with 5-fluorouracil in combination with recombinant subcutaneous human interleukin-2 and alpha-interferon by Atzpodien, J, Kirchner, H, Hänninen, E L, Menzel, T, Deckert, M, Franzke, A, Schomburg, A, Poliwoda, H

“…We treated 14 patients with progressive metastatic colorectal cancer, using a combination of subcutaneous recombinant human interleukin-2 (4.8 x 10(6) IU/m2…”
Get more information

Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma by Harstrick, A, Schmoll, H J, Köhne-Wömpner, C H, Bergmann, L, Lammers, U, Hohnloser, J, Dölken, G, Reichhardt, P, Siegert, W, Natt, F

“…Forty-eight patients with advanced testicular cancer, defined as abdominal mass greater than 10 cm, mediastinal mass greater than 5 cm, more than 20 lung…”
Get more information

In vivo tumor necrosis factor-alpha as indicator of biologic and clinical response to low-dose SC recombinant interleukin 2 by Meffert, M, Schomburg, A, Hänninen, E L, Menzel, T, Vocke, S, Dallmann, I, Grosse, J, Duensing, S, Buer, J, Kirchner, H

“…The effect of low-dose human recombinant interleukin-2 (rIL-2) on the induction of secondary tumor necrosis factor-alpha (TNF-alpha) in vivo was studied in 16…”
Get more information

Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alpha by Atzpodien, J, Körfer, A, Palmer, P A, Franks, C R, Poliwoda, H, Kirchner, H

“…We treated 17 patients who had progressive metastatic renal carcinoma with a combination of subcutaneous recombinant human interleukin-2 (administered every 12…”
Get more information

Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapy by Schomburg, A, Kirchner, H, Lopez-Hänninen, E, Menzel, T, Rudolph, P, Körfer, A, Fenner, M, Poliwoda, H, Atzpodien, J

“…A total of 107 cancer patients were treated with 148 cycles of subcutaneous (SC) immunotherapy employing interleukin-2 (rIL-2) and/or interferon-alpha…”
Get more information

Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas by Bokemeyer, C, Harstrick, A, Schmoll, H J, Köhne-Wömpner, C H, Schöffski, P, Poliwoda, H

“…Twenty-eight patients with non-pretreated metastatic soft tissue sarcomas were entered on a treatment protocol of rapidly alternating epirubicin/dacarbazine…”
Get more information